Jane Street Group, LLC Corcept Therapeutics Inc Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$29.51 - $46.26 $377,728 - $592,128	12,800 New	12,800 $592,000
Q1 2022 May 17, 2022	SELL	$16.53 - $25.21 $1.41 Million - $2.16 Million	-85,500 Reduced 72.34%	32,700 $736,000
Q4 2021 Feb 15, 2022	BUY	$17.1 - $23.34 $1.65 Million - $2.25 Million	96,500 Added 444.7%	118,200 $2.34 Million
Q3 2021 Nov 16, 2021	BUY	$19.68 - $22.53 $216,480 - $247,830	11,000 Added 102.8%	21,700 $427,000
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $149,775 - $183,225	-7,500 Reduced 41.21%	10,700 $235,000
Q4 2020 Feb 17, 2021	SELL	$16.78 - $27.3 $167,800 - $273,000	-10,000 Reduced 35.46%	18,200 $476,000
Q3 2020 Nov 17, 2020	SELL	$12.46 - $19.98 $38,626 - $61,938	-3,100 Reduced 9.9%	28,200 $491,000
Q2 2020 Aug 17, 2020	SELL	$11.0 - $18.26 $1.5 Million - $2.49 Million	-136,400 Reduced 81.34%	31,300 $526,000
Q4 2018 Feb 15, 2019	BUY	$11.29 - $17.19 $1.64 Million - $2.5 Million	145,400 Added 652.02%	167,700 $2.24 Million
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $273,621 - $348,995	22,300 New	22,300 $313,000

361

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.